Current stock page

Stock Analysis

Universal Health Services, Inc. (UHS) Stock Analysis

Universal Health Services, Inc. (UHS) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

UHS Stock Analysis Summary

Universal Health Services, Inc. (UHS) currently has an AIQ Score of 60/100, indicating a neutral setup. Value is the strongest factor at 73/100. Momentum is the weakest current factor at 37/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Oct 30, 2026 · Market-close data

UHS at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$176.05
AIQ Score60/100
Overall ViewNeutral
Technical Analysis ConsensusStrong Sell
Market Cap$10.34B
P/E Ratio (TTM)6.92
Forward P/E—
EPS (quarter ended 2026-06-30)$6.01
Revenue (quarter ended 2026-06-30)$4.64B
Dividend Yield (TTM)0.47%
Beta1.06
Volume582.1K
52-week range$140.08-$246.33
RSI 1449.21
50-Day SMA$177.22
200-Day SMA$177.10
Analyst Price Target$189.27
Next EarningsFeb 24, 2027
As of Oct 30, 2026 · Market close

UHSUniversal Health Services, Inc.

Healthcare / Medical - Care Facilities

Low Priority

Above Peers

NeutralEdge 7/10
$176.05−$0.56 (−0.32%)

Latest quote

  • Momentum
    37
  • Value
    73
  • Quality
    70
  • Risk resilience
    54
  • Sentiment
    —
algovestiq.comScore data as of Oct 30, 2026

UHS Stock Analysis Summary

Universal Health Services, Inc. (UHS) currently has an AIQ Score of 60/100, indicating a neutral setup. Value is the strongest factor at 73/100. Momentum is the weakest current factor at 37/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Oct 30, 2026 · Market-close data
AIQ Composite Posture: Mixed

In a neutral regime, UHS has AIQ Score of 60/100 with Value base of 73/100 and fading Momentum at 37/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Value (73/100) leads while Momentum (37/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · -0.32% stock move · UHS classified in Medical - Care Facilities.

Current Evidence

NeutralUHS is in a neutral AIQ regime; Value is the strongest visible factor at 73/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is UHS Bullish or Bearish Right Now?

UHS currently has a neutral overall setup. Value is the strongest factor at 73/100, while Momentum is weakest at 37/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.

Bull Case
  • - Quality is supportive at 70/100.
  • - Analyst target implies +7.51% upside from the latest quote.
Bear Case
  • - Momentum is weak at 37/100.
  • - Price is -0.28% below its 200-day SMA.
  • - Technical consensus has more sell votes than buy votes (31 vs 6).

Current Consensus

UHS's Technical Analysis Consensus is currently Strong Sell, with 6 buy, 8 neutral, and 31 sell votes. UHS's 14-day RSI is 49.21, which places the stock in a neutral momentum range. UHS's beta is 1.06, indicating market sensitivity broadly in line with the market.

Signal Confidence
High agreement

What Changed in UHS?

The largest recent change in UHS is Momentum moving down by 42.0 points over the available 7-day comparison window. Value remains the strongest visible factor.

AIQ Score
-12.0
Momentum
-42.0
Quality
+0.0
Risk
-7.0

What Would Change the UHS Outlook?

The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

UHS Decision Framework

Public evidence layers, setup checks, and risk context for Universal Health Services, Inc..

Universal Health Services, Inc. (UHS) Stock Analysis

Universal Health Services, Inc. has an AIQ Score of 60/100 in a Neutral regime. Value is strongest at 73/100. Beta is 1.03, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextUHS is in a Neutral AIQ regime with score 60/100.
Signal ConflictThe primary conflict is that value leads at 73/100 while momentum lags at 37/100.
Factor EvidenceMomentum 37/100 · Value 73/100 · Quality 70/100 · Risk 54/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Value is the strongest factor at 73/100.

TimingFail

Momentum is 37/100 and RSI (14) is 49.2.

Regime fitWait

UHS is in a Neutral regime at 60/100.

Risk controlWait

Risk factor is 54/100 with beta 1.03 and annual volatility 32.54%.

ConflictWait

Current conflict: value leads at 73/100 while momentum lags at 37/100.

AIQ Score
60/100
Price
$176.05
Beta
1.03
RSI (14)
49.2

UHS Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

UHS Fundamentals

UHS valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$4.64B
Net income
$358.45M
Free cash flow
$215.67M
View full UHS fundamental analysis

UHS Technical Analysis

UHS technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Sell
RSI 14
49.21
Price vs SMA-50
-0.34%
View full UHS technical analysis

UHS Stock Catalysts

Track UHS earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Feb 24, 2027
Analyst target
$189.27
News items
0
View UHS earnings and stock catalysts

UHS Dividend Analysis

UHS dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.45%
Annual dividend
$0.80
Payout ratio
3.25%
View UHS dividend history and analysis

UHS Financial Data

UHS revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$4.64B
EPS
$6.01
Periods
3
View UHS financials

UHS Risk Analysis

UHS volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.06
Risk score
54/100
1Y volatility
32.54%
View UHS risk analysis

UHS Stock News

UHS stock news, market tone, recent headlines, and catalyst context.

News items
0
Updated
—
Sentiment
—
Read UHS stock news

UHS vs Healthcare Services / Managed Care Peers

Current peer cohort: UHS · UNH · ALHC · BKD · CAH. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
UHS
Current stock
60/10073/10037/10054/100-0.7132.54%Current
UNH
UnitedHealth Group
59/10058/10081/10051/1000.4934.75%UHS vs UNH
ALHC
Alignment Healthcare
43/10042/10051/10046/100-0.8869.56%UHS vs ALHC
BKD
Brookdale Senior Living
50/10065/10045/10046/1000.4539.17%UHS vs BKD
CAH
Cardinal Health
53/10056/10073/10055/1001.4329.94%UHS vs CAH
Pairwise Compare links: UNH · ALHC · BKD · CAHUHS vs UNHUHS vs ALHCUHS vs BKDUHS vs CAHCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Oct 30, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a UHS stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

3 recent quarterly periods are available for review.

Checked Oct 31, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
6.92
As of Oct 29, 2026
Revenue growth
—
Gross margin
90.69%
Current debt / equity
0.7
Latest quarterly evidence

Latest period Jun 30, 2026.

Review fundamentals
Quarter revenue
$4.64B
Quarter net income
$358.45M
Quarter free cash flow
$215.67M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Mixed
Momentum
Mixed
RSI 14
49.21
MACD
0.82

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
54/100
Beta
1.03
Annual volatility
32.54%
Max drawdown
-42.19%

UHS Stock FAQ

What is UHS stock price today?

Universal Health Services, Inc.'s current stock price is $176.05. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is UHS bullish or bearish right now?

UHS's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is UHS's market cap?

UHS's market cap is $10.34B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is UHS's current P/E ratio?

UHS's current P/E ratio is 6.92 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is UHS's RSI?

UHS's 14-day RSI is 49.21 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is UHS above its 50-day and 200-day moving averages?

UHS is -0.34% from its 50-day SMA and -0.28% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is UHS's next earnings date?

UHS's next earnings date is currently listed as Feb 24, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does UHS pay a dividend?

UHS's dividend yield is 0.47% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.